{"Nomor": 61817, "Judul": "LITERATURE REVIEW OF COVID-19 VACCINES EFFICACY AND SAFETY ON OLDER PEOPLE", "Abstrak": "Covid-19 pandemic begin at late 2019, currently 4 type of vaccines which is available on the\nmarket which are mRNA, viral vector, protein-based and inactivated vaccines. This research focus\non efficacy and safety of Covid-19 vaccines on older people. The objective are to identify the\nvaccine efficacy on prevention of COVID-19 infection, hospitalization, death and the safety of\nvaccines. Searching engine used include PubMed, Google Scholar and Scopus. The sources was\nlimited to journals published from 2020 onwards. The inclusion criteria included the participant\nwho are 60y.o. and older with no previous infection of Covid-19, phase 1,2 and 3 clinical trial,\ncase-control study and cohort, article Scimago Index Q1~Q3. The exclusion criteria are patient\nunder 60y.o. , patient had infected by Covid-19, article type such as commentary, review and\nshort reports and article Scimago index below Q3. As the results, fifteen journals are included.\nPrimary efficacy of Moderna 86.4%, Pfizer-BioNTech 93.7%, Novavax 88.9%, AstraZeneca,\n65.5%, Sputnik V 93.7% and SinoVac 51.1%. Secondary efficacy, prevention of hospitalization,\nafter 1\nst\ndose Pfizer-BioNTech 43%, AstraZeneca 37%, SinoVac 38.6%. After 2\nnd\ndose Pfizer-\nBioNTech 85%, AstraZeneca 94% and SinoVac 85.6%. Prevention of death, Pfizer-BioNTech 50.1%\nafter 1\nst\ndose, SinoVac 86.8%, Covishield 67.76%, Covaxin 100% after 2\nnd\ndose. The results show\nall vaccines has a high level of safety aspect, only causing mild AEs. In conclusion, all vaccines are\nreported had efficacy on prevention of infection> 50%, prevention on hospitalization\n37%~43%(1\nst\ndose), 85%~94%(2\nnd\ndose), prevention on death 67.76%~100% (2\nnd\ndose), all vaccine\nonly causing mild AEs with rare serious AEs and none related death reported.", "Daftar File": {"ABSTRAK Lim Tzong Yje": "https://digilib.itb.ac.id/gdl/download/236878"}, "Penulis": "Lim Tzong Yje [11617103]", "Kontributor / Dosen Pembimbing": ["Dr. Maria Immaculata Iwo", "apt. Dhyan Kusuma Ayuningtyas, S.Farm., M.Si."], "Jenis Koleksi": "Tugas Akhir", "Penerbit": "Farmasi Klinik dan Komunitas", "Fakultas": "Sekolah Farmasi", "Subjek": "", "Kata Kunci": "COVID-19, Vaccine, Efficacy, Safety, Older People", "Sumber": "", "Staf Input/Edit": "yana mulyana", "File": "1 file", "Tanggal Input": "28 Sep 2021"}